首頁 > 市場調查報告書 > 醫療設備

泌尿科

市場調查報告書

商品編碼

1439689

全球泌尿外科設備市場：洞察、競爭格局、市場預測：2030 年

Urology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球泌尿外科設備市場規模為354.999億美元。預計到 2030 年，該市場將達到 498.0605 億美元，2024 年至 2030 年的預測期內複合年增長率為 5.67%。泌尿外科設備的需求主要由泌尿生殖疾病盛行率上升和老年人口負擔增加等主要因素所推動。此外，糖尿病和高血壓盛行率的上升、產品上市的增加等預計將對 2024-2030 年預測期內的市場成長產生正面影響。

影響泌尿外科設備市場成長的主要因素之一是全球膀胱癌、泌尿道感染和腎結石等泌尿外科疾病的盛行率不斷上升。根據 2020 年全球癌症觀察站數據，2020 年全球報告了約 573,000 例膀胱癌病例。預計到2040年這數字將達到91.3萬人。根據上述消息來源，2020年全球約有431,000例新診斷的腎癌和腎盂癌病例，預計到2040年將增至606,000例。

除上述數據外，國際腎臟病學會指出，到 2022 年，全球將有 8.5 億人患有某種形式的腎臟疾病。此外，全世界有 530 萬至 1,050 萬人需要透析或移植。

本報告研究了全球泌尿外科設備市場，並提供了市場概述，包括按產品類型、最終用戶、地區和參與市場的公司概況劃分的趨勢。

Boston Scientific Corporation
Baxter
B. Braun Melsungen AG
Medtronic
Laborie
Potent Medical
Advin Health Care
KARL STORZ SE & Co. KG
Fresenius Medical Care AG & Co. KGaA
Coloplast Corporation
Intuitive Surgical
Nipro
Olympus Corporation
Asahi Kasei Medical
Nikkiso Co., Ltd.
Well Lead Medical Co., Ltd
Applied Medical Resources Corporation
DirexGroup
Richard Wolf GmbH
Cardinal Health

第9章KOL瀏覽量

第 10 章專案方法

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0531

Urology Devices Market By Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, Others], Lasers And Lithotripsy Devices, Urology Consumables, Others), By End-User (Hospitals, Speciality Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of urogenital diseases and its increasing risk factors such as high blood pressure, diabetes, among others

The global Urology Devices Market was valued at USD 35,499.90 million in 2023, growing at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 49,806.05 million by 2030. The demand for urology devices is primarily being boosted owing to key factors such as the rising prevalence of urogenital diseases and the escalating burden of the geriatric population. Furthermore, the rising prevalence of diabetes and high blood pressure coupled with increasing product launches, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

Urology Devices Market Dynamics:

One of the key factors influencing the growth of the urology devices market is the rising prevalence of urological conditions such as bladder cancer, urinary tract infection, kidney stones, and others across the world. According to Global Cancer Observatory data 2020, globally about 573,000 cases of bladder cancer were reported in 2020. It has been estimated that by 2040, the number is likely to reach 913,000. As per the above-mentioned source, worldwide around 431,000 new cancer cases of kidney and renal pelvis were diagnosed in 2020 and the cases are expected to increase to 606,000 by 2040.

In addition to the above data, the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022. The source further mentioned that between 5.3 and 10.5 million people needed dialysis or transplantation globally.

The increasing product development activities for urology devices meant for the treatment of urogenital disorders are further expected to aid in the growth of the global urology devices market. In July 2022, Otsuka Pharmaceutical Factory, Inc. announced the launch of the OT-Balloon Catheter, an intermittent urological catheter, for use during self-catheterization for people having difficulty urinating spontaneously for various reasons. The catheter is temporarily implanted in the bladder by inflating the balloon at the tip of the catheter during the night or when going out. The catheter can be used according to the patient's lifestyle, as self-catheterization is not necessary while it is in place.

However, complications associated with different urology devices, and limited access to urology care, particularly in low-income countries, among others may act as barriers to the urology devices market growth.

The COVID-19 pandemic had a negative impact on the market growth of urology devices as during the initial few months owing to the lockdown impositions and border closures, the manufacturing, supply, import, export, and other related activities of the urology devices market was hampered. The hospitals, clinics, and other medical facilities were overburdened with managing and treating patients affected by COVID-19. Except for some emergency procedures, all other elective procedures were suspended across the globe. This caused a delay or cut down on different kinds of urological services such as outpatient clinics, outpatient investigations and procedures, and urological surgeries with the duration of delay ranging from about 2 weeks to 8 weeks. The healthcare services for non-urgent urological conditions such as benign tumors, infertility, sexual medicine, benign scrotal conditions, female urinary incontinence, renal stone, and bladder stone among others at outpatient clinics were majorly affected. On the other hand, potentially urgent urological conditions such as renal transplantation and ureteric stone were less affected. The number of outpatient investigations including prostate biopsy, ESWL, cystoscopy, urodynamic study, uroflowmetry, and others was suspended for the time being during the pandemic owing to their non-urgency. However, with the introduction of vaccines and the masses being vaccinated against COVID-19 and owing to the resumption of activities in industries including the healthcare sector, the market for urology devices is set to recover during the forecast period.

Urology Devices Market Segment Analysis:

Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, Others], Lasers and Lithotripsy Devices, Urology Consumables, Others), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the urology devices market, the Dialysis Devices segment held a revenue share of 41.39% in the year 2023.

This can be attributed to the application, technical advantages, and increasing product development activities such as product launches and regulatory approvals of dialysis devices during the given forecast period.

Dialysis devices are used to conduct the process of dialysis which is considered the life-sustaining treatment for patients suffering from end-stage kidney disease. There are dialysis devices for both hemodialysis and peritoneal dialysis. Dialysis devices are composed of a hemodialyzer (artificial kidney) where blood gets filtered out. Dialysis devices are also composed of several blood pumps and pressure monitors that facilitate the movement of blood from the patient to the machine and back to the patient in a hustle-free manner.

Along with this, the growing focus of manufacturers on designing and developing new dialysis devices is going to accelerate the demand for the same. For example, in September 2019, Fresenius Medical Care announced the launch of a new dialysis machine in China. Also, in September 2022, Terumo Corporation received regulatory approval from the National Medical Products Administration (NMPA) to manufacture and market a novel neutral peritoneal dialysis solution.

Therefore, the benefits associated with dialysis devices along with product development activities would increase their demand in the market, which will drive the growth of the overall global urology devices market during the forecast period.

North America is expected to dominate the overall Urology Devices Market:

North America held the largest share of 42.03% in the urology devices market in 2022. This domination is due to factors such as the increasing prevalence of urology diseases such as chronic kidney diseases, prostate cancer, and urinary tract infection, among others, and their risk factors. Furthermore, the increasing healthcare expenditure, rising research and development activities in the region and surging launch and approval of new devices are also driving the market growth of urology devices in North America.

According to statistics cited by the American Cancer Society, in 2023, about 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women) will be reported in the US. In 2020, the Kidney Foundation of Canada stated that about 12% of men and 6% of women in the country will face the problem of kidney stones at some point in their life. The Globocan statistics (2023), stated that in 2020, 29,972 new cases of prostate cancer were reported in Canada.

In events of cancer spread, depending on the degree of metastasis, different procedures are employed such as laparoscopic nephrectomy and robot-assisted nephrectomy. Different products such as ureteroscopes, surgical robotic systems, and cystoscopes, among other urology products, are used for either treatment or diagnosis of urogenital disease, leading to its increased demand in the market.

The product development activities and product approvals are further expected to drive the demand for urology devices in the region. For instance, in January 2022, Applaud Medical, Inc., received the Breakthrough Device designation from the US FDA for its Acoustic Enhancer technology. The Acoustic Enhancer technology is designed to be used in conjunction with Ureteroscopy with Laser Lithotripsy (URS-LL).

Therefore, the interplay of all the above-mentioned factors is expected to drive the market growth for urology devices in the region during the forecast period from 2024-2030.

Urology Devices Market Key Players:

Some of the key market players operating in the Urology Devices market include Boston Scientific Corporation, Baxter, B. Braun Melsungen AG, Medtronic, Laborie, Potent Medical, Advin Health Care, KARL STORZ SE & Co. KG, Fresenius Medical Care AG & Co. KGaA, Coloplast Corporation, Intuitive Surgical, Nipro, Olympus Corporation, Asahi Kasei Medical, Nikkiso Co., Ltd., Well Lead Medical Co., Ltd, Applied Medical Resources Corporation, DirexGroup, Richard Wolf GmbH, Cardinal Health, and others.

Recent Developmental Activities in the Urology Devices Market:

In February 2023, Boston Scientific Corporation received US FDA 510(k) clearance for LithoVue(TM) Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.

In May 2022, In May 2022, Teleflex Incorporated, a leading global provider of medical technologies, received National Medical Products Administration (NMPA) approval for its UroLift® System in China.

In December 2020, Medtronic announced the US commercial launch of the first and only pediatric and neonatal acute dialysis machine named Carpediem(TM) system.

Key Takeaways from the Urology Devices Market Report Study

Market size analysis for current urology devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the urology devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global urology devices market.

Various opportunities available for the other competitor in the urology devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current urology devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for urology devices market growth in the coming future?

Target Audience who can be benefited from this Urology Devices Market Report Study

Urology devices products providers

Research organizations and consulting companies

Urology devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in urology devices

Various end-users who want to know more about the urology devices market and the latest technological developments in the urology devices market.

Frequently Asked Questions for the Urology Devices Market:

1. What are urology devices?

Urology Devices are medical devices that are employed in the diagnosis and treatment of indications specific to the urogenital system. The commonly used urology devices are lithotripsy devices, lasers, dialysis machines, urinary catheters, ureteral stents, bladder scanners, incontinence devices, and many others.

2. What is the market for Global Urology Devices?

The global urology devices market was valued at USD 35,499.90 million in 2022 and is likely to register a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 49,806.05 million by 2030.

3. What are the drivers for the global urology devices market?

The demand for urology devices is primarily being boosted owing to key factors such as the rising prevalence of urogenital diseases and the escalating burden of the geriatric population. Furthermore, the rising prevalence of diabetes and high blood pressure coupled with increasing product launches, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

4. Who are the key players operating in the global urology devices market?

Some of the key market players operating in the urology devices market include Boston Scientific Corporation, Baxter, B. Braun Melsungen AG, Medtronic, Laborie, Potent Medical, Advin Health Care, KARL STORZ SE & Co. KG, Fresenius Medical Care AG & Co. KGaA, Coloplast Corporation, Intuitive Surgical, Nipro, Olympus Corporation, Asahi Kasei Medical, Nikkiso Co., Ltd., Well Lead Medical Co., Ltd, Applied Medical Resources Corporation, DirexGroup, Richard Wolf GmbH, Cardinal Health, and others.

5. Which region has the highest share in the Urology Devices market?

North America is expected to dominate the overall urology devices market during the forecast period from 2024-2030. This domination is due to factors such as the increasing prevalence of urology diseases such as chronic kidney diseases, prostate cancer, and urinary tract infection, among others, and their associated risk factors. Furthermore, the increasing healthcare expenditure, rising research and development activities in the region and surging launch and approval of new devices are also driving the market growth of urology devices in North America.

1.Urology Devices Market Report Introduction

2. Urology Devices Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Urology Devices Market Key Factors Analysis

4.1. Urology Devices Market Drivers
- 4.1.1. Increasing prevalence of urogenital diseases and their risk factors
- 4.1.2. Growing adoption of minimally invasive and technologically advanced urology devices
- 4.1.3. Increasing focus on the development of urology devices for pediatric patients
4.2. Urology Devices Market Restraints and Challenges
- 4.2.1. Complications associated with different urology devices
- 4.2.2. Limited access to urology care, particularly in low-income countries
4.3. Urology Devices Market Opportunities
- 4.3.1. Increasing Investments in establishing new urology-based healthcare facilities
- 4.3.2. Integration of artificial intelligence (AI) in urology devices

5. Urology Devices Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urology Devices Market

7. Urology Devices Market Layout

7.1. By Product Type
- 7.1.1. Dialysis devices
- 7.1.2. Endoscopes
  - 7.1.2.1. Ureteroscopes
  - 7.1.2.2. Nephroscopes
  - 7.1.2.3. Resectoscopes
  - 7.1.2.4. Others
- 7.1.3. Lasers and lithotripsy devices
- 7.1.4. Urology consumables
- 7.1.5. Others
7.2. By End-User
- 7.2.1. Hospitals
- 7.2.2. Specialty Clinics
- 7.2.3. Others
7.3. By Geography
- 7.3.1. North America Urology Devices Market Size in USD million (2021-2030)
  - 7.3.1.1. United States Urology Devices Market Size in USD million (2021-2030)
  - 7.3.1.2. Canada Urology Devices Market Size in USD million (2021-2030)
  - 7.3.1.3. Mexico Urology Devices Market Size in USD million (2021-2030)
- 7.3.2. Europe Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.1. France Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.2. Germany Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.4. Italy Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.5. Spain Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Urology Devices Market Size in USD million (2021-2030)
- 7.3.3. Asia-Pacific Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.1. China Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.2. Japan Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.3. India Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.4. Australia Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.5. South Korea Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Urology Devices Market Size in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW) Urology Devices Market Size in USD million (2021-2030)
  - 7.3.4.1. Middle East Urology Devices Market Size in USD million (2021-2030)
  - 7.3.4.2. Africa Urology Devices Market Size in USD million (2021-2030)
  - 7.3.4.3. South America Urology Devices Market Size in USD million (2021-2030)

8. Urology Devices Market Company and Product Profiles

8.1. Boston Scientific Corporation
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Baxter
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. B. Braun Melsungen AG
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Medtronic
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Laborie
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Potent Medical
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Advin Health Care
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. KARL STORZ SE & Co. KG
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Fresenius Medical Care AG & Co. KGaA
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Coloplast Corporation
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Intuitive Surgical
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Nipro
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Olympus Corporation
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Asahi Kasei Medical
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Nikkiso Co., Ltd.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Well Lead Medical Co., Ltd
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Applied Medical Resources Corporation
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. DirexGroup
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Richard Wolf GmbH
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Cardinal Health
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy